The following clinical factors were reported about their association with discontinuation: mental status, Tb/HIV co-infection, INH prophylaxis provision, cotrimoxazole or OI prophylaxis provision, presence of side effects, baseline CD4 counts, baseline WHO clinical stage, baseline functional status, baseline BMI level, baseline hemoglobin level and regimen substitution. The gene discussed is CD4; the disease is coinfection.